Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics
Nitric oxide (NO) is a short-lived, ubiquitous signaling molecule that affects numerous critical functions in the body. There are markedly conflicting findings in the literature regarding the bimodal effects of NO in carcinogenesis and tumor progression, which has important consequences for treatmen...
Main Authors: | Joel Mintz, Anastasia Vedenko, Omar Rosete, Khushi Shah, Gabriella Goldstein, Joshua M. Hare, Ranjith Ramasamy, Himanshu Arora |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/2/94 |
Similar Items
-
Oncological Response and Predictive Biomarkers for the Checkpoint Inhibitors in Castration-Resistant Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis
by: Omar Fahmy, et al.
Published: (2021-12-01) -
Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives
by: Sara Elena Rebuzzi, et al.
Published: (2022-02-01) -
Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond
by: Sree M. Lanka, et al.
Published: (2023-04-01) -
Past, Current, and Future of Immunotherapies for Prostate Cancer
by: Adeline N. Boettcher, et al.
Published: (2019-09-01) -
Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions
by: Fernando López-Campos, et al.
Published: (2022-02-01)